Eli Lilly has returned to Nimbus Therapeutics for another metabolic collaboration, this time focused on the red-hot R&D space of oral obesity therapies. The latest partnership will see Lilly pass ...

Jan 6 (Reuters) - Nimbus Therapeutics said on Tuesday it has entered into a multi-year research and licensing agreement with Eli Lilly (LLY.N), opens new tab to develop artificial intelligence-driven ...

Nimbus and Eli Lilly collaborate to develop an oral treatment for obesity, leveraging computational chemistry and structure-based drug design. The partnership builds on previous efforts targeting AMPK ...

Eighteen months after it closed and stopped production, Nimbus Brewing Co.’s fan favorite Pale Ale and Blonde Ale are back on Arizona store shelves, and the signature Monkeyshine Ale is back on tap in ...

ASICS has officially unveiled the 28th generation of its legendary GEL-NIMBUS neutral running shoe, and preorder is already open ahead of the January 9, 2026 release date. The Nimbus series has been a ...

Eli Lilly and Nimbus Therapeutics have entered into a multi-year collaboration and exclusive licensing agreement to develop an oral treatment for obesity and other metabolic diseases. Nimbus, an ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.